• Batterbee, H., De la Salle, B., McTaggart, P., Dove, C., Wild, B. & Hyde, K. (2010) Evaluation of UK NEQAS (H) HbA2 and Related Performance Data. UK NEQAS, Sheffield, UK.
  • Fodor, F.H. & Eng, C.M. (1999) Molecular Exclusion of haemoglobin SD disease by prenatal diagnosis. Prenatal Diagnosis, 19, 5860.
  • Giordano, P.C., Bakker-Verwij, M. & Harteveld, C. (2009) Frequency of a-globin gene triplications and their interactions with B-thalassaemia mutations. Hemoglobin, 33, 124131.
  • Hofvind, S., Ponti, A., Patnick, J., Ascunce, N., Njor, S., Broeders, M., Giordano, L., Frigerio, A. & Törnberg, S.; EUNICE Project and Euroscreen Working Groups., Van Hal, G., Martens, P., Májek, O., Danes, J., von Euler-Chelpin, M., Aasmaa, A., Anttila, A., Becker, N., Péntek, Z., Budai, A., Mádai, S., Fitzpatrick, P., Mooney, T., Zappa, M., Ventura, L., Scharpantgen, A., Hofvind, S., Seroczynski, P., Morais, A., Rodrigues, V., Bento, M.J., Gomes de Carvalho, J., Natal, C., Prieto, M., Sánchez-Contador Escudero, C., Zubizarreta Alberti, R., Fernández Llanes, S.B., Ascunce, N., Ederra Sanza, M., Sarriugarte Irigoien, G., Salas Trejo, D., Ibáñez Cabanell, J., Wiege, M., Ohlsson, G., Törnberg, S., Korzeniewska, M., de Wolf, C., Fracheboud, J., Patnick, J., Lancucki, L., Ducarroz, S. & Suonio, E. (2012) False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes. Journal of Medical Screening, 19, 5766.
  • Karnon, J., Peters, J., Platt, J., Chilcott, J., McGoogan, E. & Brewer, N. (2004) Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis. Health Technology Assessment, 8, 20.
  • Mai, M., Hoyer, J.D. & McClure, R.F. (2004) Use of multiple displacement amplification to amplify genomic DNA before sequencing of the δ and β haemoglobin genes. Journal of Clinical Pathology, 57, 637640.
  • NHS Sickle Cell & Thalassaemia Screening Programme (2012) Handbook for Laboratories, 3rd edn. Available at: (accessed November 19, 2013).
  • NHS Sickle Cell & Thalassaemia Screening Programme (2013) Data Report 2011/12, Trends and perfomance analysis. Available at: (accessed March 11, 2014).
  • Perseu, L., Satta, S., Moi, P., Demartis, F.R., Manunza, L., Sollaino, M.C., Barella, S., Cao, A. & Galanello, R. (2011) KLF1 gene mutations cause borderline Hb A2. Blood, 118, 44544458.
  • Stephens, A.D., Angastiniotis, M., Baysal, E., Chan, V., Fucharoen, S., Giordano, P.C., Hoyer, J.D., Mosca, A.D., Wild, B. & on behalf of the International Council for the Standardisation of Haematology (ICSH). (2011) ICSH recommendations for the measurement of Haemoglobin A2. International Journal of Laboratory Hematology, 34, 113.